INTERNATIONAL PATENT: HUVEPHARMA INC. FILES APPLICATION FOR "RECOMBINANT ATTENUATED SALMONELLA VACCINES (RASVS) AGAINST INFECTIONS BY AVIAN PATHOGENIC ESCHERICHIA COLI (APEC)"

GENEVA, Oct. 1 -- HUVEPHARMA INC. (525 Westpark Dr.Suite 230Peachtree City, GA 30269) filed a patent application (PCT/US2025/020336) for "RECOMBINANT ATTENUATED SALMONELLA VACCINES (RASVS) AGAINST INFECTIONS BY AVIAN PATHOGENIC ESCHERICHIA COLI (APEC)" on Mar 18, 2025. With publication no. WO/2025/199081, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAEK, Chang-Ho (5604 SW 215th TerNewberry, FL 32669), VANDER VEEN, Ryan (c/o Huvepharma Inc.525 Westpark Dr., Suite 230Peachtree City, GA 30269)

Abstract: The present disc...